PCRRT on ECMO Norma J Maxvold Pediatric Critical Care.
Chronic Kidney Disease. Stage 5 0.2% Stage 4: 0.2% Stage 3: 4.3% Stage 2: 3.0% Stage 1: 3.3% Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence.
CKD ML/LH 17.3.10. Chronic Kidney Disease Are we correctly diagnosing CKD? Have we the correct patients on our CKD register? Are we managing them correctly?
Effects of Renal Disease on Pharmacokinetics Juan J. L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program Office of Clinical Research Training.
STANDARDIZED ORDER PROTOCOLS: EFFICIENCY AT THE EXPENSE OF RESIDENT EDUCATION? Ambarish Bhat, MD Martina Jelley, MD University of Oklahoma College of Medicine.
DFM Fellows Summer 2010. Objectives Understand the basics of fluid administration Review basics of various fluid options Be able to calculate maintenance.
Journal Club: AKI and timing of RRT in Post-op ITU Patients Dr Andrew Stein Consultant in Renal and Acute Medicine UHCW, Coventry.
Evaluation of Methods Used to Estimate Vancomycin Pharmacokinetic Parameters By Hanh Huynh, PSIII.
2 Disorders of the Posterior Pituitary Diabetes Insipidus Syndrome of Inappropriate Antidiuretic Hormone (SAIDH)
Background and Controversies in Dosing and Adjustment of Chemotherapy Agents Dana Cole, BScPharm, PharmD Oncology Drug Information Specialist BC Cancer.
Presented by Rebecca Singleton Turner Syndrome Overview
Chronic Kidney Disease For the PCM
